T lymphocytes: a role in hypertension?

Area of Science:

• Immunology
• Cardiovascular Science
• Nephrology

Background:

• Low-grade inflammation contributes to cardiovascular disease, particularly hypertension.
• Leukocytes and macrophages are involved in inflammatory responses.
• T lymphocyte subsets are increasingly recognized in hypertension pathogenesis.

Purpose of the Study:

• To review the role of T lymphocyte subsets in hypertension and vascular remodeling.
• To highlight the potential therapeutic implications of targeting T cells in cardiovascular and renal diseases.

Main Methods:

• Review of recent scientific literature and data.
• Analysis of the involvement of various T lymphocyte subsets (Th1, Th2, Th17, Treg).
• Examination of the link between T cells, oxidative stress, and blood pressure.

Main Results:

• Specific T lymphocyte subsets (T-helper 1, T-helper 2, T-helper 17, regulatory T cells) are critical in angiotensin II, deoxycorticosterone salt-sensitive, and Dahl salt-sensitive hypertension.
• These T cells also drive vascular remodeling progression.
• Oxidative stress in the brain may trigger T lymphocyte-mediated inflammation, elevating blood pressure.

Conclusions:

• Emerging data implicate T lymphocytes in the mechanisms of hypertension and vascular remodeling.
• These findings pave the way for novel therapeutic targets.
• Interventions focused on T lymphocytes hold potential for improving human cardiovascular and renal disease outcomes.